Domů › Chronická lymfocytární leukemie › Washington › Seattle
Klinické studie Chronická lymfocytární leukemie v Seattle, WA
20 studií pro Chronická lymfocytární leukemie hledá účastníky v lokalitách v Seattle a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- a dalších 1
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Probíhá náborFáze 1/2
- Research Site, Seattle
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Probíhá náborFáze 3
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-First Hill, Seattle
- FHCC at Northwest Hospital, Seattle
- a dalších 1
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Probíhá náborFáze 3
- Swedish Medical Center Swedish Cancer Institute First Hill Campus, Seattle
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Probíhá náborFáze 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Probíhá náborFáze 3
- Fred Hutchinson Cancer Research Center, Seattle
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
Probíhá náborFáze 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Probíhá náborFáze 3
- Fred Hutchinson Cancer Research Center, Seattle
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Probíhá náborFáze 3
- Fred Hutchinson Cancer Research Center, Seattle
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Probíhá náborFáze 2
- Fred Hutchinson Cancer Center, Seattle
Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Probíhá náborFáze 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Probíhá náborFáze 1
- Fred Hutch Cancer Center, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Probíhá náborFáze 2Vítáni zdraví dobrovolníci
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial
Probíhá náborFáze 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma
Probíhá náborFáze 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Probíhá náborFáze 4
- Swedish Cancer Institute, Seattle
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Probíhá náborFáze 4
- Swedish Cancer Institute, Seattle
Study of SGR-1505 in Mature B-Cell Neoplasms
Probíhá náborFáze 1
- Fred Hutchinson Cancer Center, Seattle
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Probíhá náborFáze 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Probíhá náborFáze 1
- Swedish Cancer Institute, Seattle
Studie Chronická lymfocytární leukemie v jiných městech
- Boston, MA31 studií
- Columbus, OH28 studií
- Durham, NC27 studií
- Washington, DC22 studií
- Rochester, MN19 studií
- New York City, NY18 studií
- Houston, TX17 studií
- Baldwin Park, CA16 studií
- Milwaukee, WI15 studií
- Cincinnati, OH14 studií
- Chicago, IL14 studií
- Nashville, TN13 studií
Další studie v Seattle
- Nemalobuněčný plicní karcinom53 studií
- Rakovina (všechny typy)49 studií
- Rakovina prostaty42 studií
- Akutní myeloidní leukemie40 studií
- Rakovina prsu39 studií
- Metastatický karcinom39 studií
- Kolorektální karcinom34 studií
- Rakovina plic33 studií
- Rakovina vaječníků30 studií
- Mnohočetný myelom22 studií
- Myelodysplastické syndromy21 studií
- Akutní lymfoblastická leukemie21 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.